{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:02:23Z","timestamp":1790269343317,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.parkreldis.2012.11.005","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T10:19:41Z","timestamp":1354789181000},"page":"316-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Amantadine improves gait in PD patients with STN stimulation"],"prefix":"10.1016","volume":"19","author":[{"given":"Hiu-Fai","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanth L.","family":"Kukkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Merello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-Yang","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yan","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2012.11.005_bib1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/mds.23467","article-title":"Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson\u2019s disease","volume":"26","author":"Post","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa060281","article-title":"A\u00a0randomized trial of deep brain stimulation for Parkinson's disease","volume":"355","author":"Deuschl","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib3","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199810153391603","article-title":"Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease","volume":"339","author":"Limousin","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib4","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJMoa000827","article-title":"Deep brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease","volume":"345","author":"The Deep-Brain Stimulation for Parkinson's Disease Study Group","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.parkreldis.2012.11.005_bib5","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/archneurol.2011.182","article-title":"Ten-year outcome of subthalamic stimulation in Parkinson disease. A blinded evaluation","volume":"68","author":"Castrioto","year":"2011","journal-title":"Arch Neurol"},{"issue":"Suppl. 14","key":"10.1016\/j.parkreldis.2012.11.005_bib6","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1002\/mds.20957","article-title":"Deep brain stimulation: postoperative issues","volume":"21","author":"Deuschl","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib7","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa035275","article-title":"Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease","volume":"349","author":"Krack","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib8","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/brain\/awh571","article-title":"Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up","volume":"128","author":"Rodr\u00edguez-Oroz","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib9","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1136\/jnnp.2005.063206","article-title":"Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up","volume":"76","author":"Schupbach","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000314357","article-title":"Patient-specific model-based investigation of speech intelligibility and movement during deep brain stimulation","volume":"88","author":"\u00c5str\u00f6m","year":"2010","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib11","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jama.1969.03160070046011","article-title":"Amantadine in the treatment of Parkinson's Disease","volume":"208","author":"Schwab","year":"1969","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib12","first-page":"CD003468","article-title":"Amantadine in Parkinson's disease","volume":"1","author":"Crosby","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl. 3","key":"10.1016\/j.parkreldis.2012.11.005_bib13","first-page":"S2","article-title":"The movement disorder society evidence-based medicine update: treatment for the motor symptoms of Parkinson's disease","volume":"26","author":"Fox","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib14","first-page":"CD003467","article-title":"Amantadine for dyskinesia in Parkinson's disease","volume":"2","author":"Crosby","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.parkreldis.2012.11.005_bib15","doi-asserted-by":"crossref","first-page":"e15298","DOI":"10.1371\/journal.pone.0015298","article-title":"Amantadine for dyskinesia in Parkinson's disease: a randomized controlled trial","volume":"5","author":"Sawada","year":"2010","journal-title":"PLos One"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0140-6736(70)90634-3","article-title":"Controlled trial of amantadine hydrochloride in Parkinson's disease","volume":"295","author":"Parkes","year":"1970","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.parkreldis.2012.11.005_bib17","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.parkreldis.2006.05.018","article-title":"Drug intervention for freezing of gait resistant to dopaminergic therapy: a pilot study","volume":"12","author":"Kondo","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.parkreldis.2011.03.010","article-title":"Effect of intravenous amantadine on dopaminergic-drug-resistant freezing of gait","volume":"17","author":"Kim","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/mds.21458","article-title":"Predictors of freezing in Parkinson\u2019s Disease: a survey of 6,620 patients","volume":"22","author":"Macht","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/01.wnl.0000303972.16279.46","article-title":"STN-DBS frequency effects on freezing of gait in advanced Parkinson's disease","volume":"71","author":"Moreau","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib21","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1212\/01.wnl.0000339385.187472.7d","article-title":"STN-DBS frequency effects on freezing of gait in advanced Parkinson disease","volume":"72","author":"Brozova","year":"2009","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.parkreldis.2012.11.005_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(12)70106-0","article-title":"Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomized, placebo-controlled trial","volume":"11","author":"Moreau","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1472-8206.2009.00798.x","article-title":"Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease","volume":"24","author":"Devos","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0006-8993(94)90821-4","article-title":"Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism","volume":"662","author":"Mizoguchi","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0361-9230(96)00211-0","article-title":"Inhibitory effect of MK-801 on amantadine-induced dopamine release in the rat striatum","volume":"41","author":"Takahashi","year":"1996","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.parkreldis.2012.11.005_bib26","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.0b013e31824e8f0d","article-title":"Amantadine: the journey from fighting flu to treating Parkinson disease","volume":"78","author":"Hubsher","year":"2012","journal-title":"Neurology"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802012004385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802012004385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:13:28Z","timestamp":1761178408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802012004385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1353802012004385"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2012.11.005","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amantadine improves gait in PD patients with STN stimulation","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2012.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2012 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}